基于CT图像的肺腺癌EGFR突变预测:瘤内与瘤周影像组学、深度学习及融合模型的比较研究
本研究回顾性收集两所医院826例肺腺癌患者的胸部CT数据,利用nnUNet分割肿瘤并提取瘤内及瘤周2–10 mm区域的影像组学和深度学习特征,构建融合模型预测EGFR突变状态。基于瘤内+瘤周2 mm区域的影像组学模型在内部和外部验证集AUC分别为0.843和0.803,3D深度学习模型AUC分别为0.839和0.814,soft voting融合模型AUC最高,内部和外部验证集分别为0.925和0.889。
要点
- 基于瘤内及瘤周2 mm区域的影像组学模型在外部验证集预测EGFR突变AUC为0.803。
- 基于相同区域的3D深度学习模型在外部验证集AUC为0.814,优于2D和2.5D模型。
- soft voting融合模型在外部验证集AUC为0.889,显著高于硬投票、早期融合或任何单模态模型。
核心结论
- 联合基于瘤内和瘤周区域的影像组学与深度学习模型,是捕捉肺腺癌全面影像特征的有效方法;采用soft voting的多模态融合策略整合了各模态优势,为先进影像特征提取以支持个性化治疗提供了稳健框架。
研究设计与样本
- 回顾性研究,纳入两所医院共826例肺腺癌患者,中心1数据用于模型训练和内部验证,中心2数据用于外部验证;使用nnUNet网络分割肿瘤,衍生瘤内及瘤周2 mm、4 mm、6 mm、8 mm、10 mm的感兴趣体积,采用PyRadiomics提取影像组学特征,并以Lasso和多种机器学习算法建模;深度学习模型输入为不同VOI衍生的2D、2.5D和3D图像;将表现最佳的影像组学和深度学习模型与临床模型进行特征级融合及决策级融合(硬投票、软投票、堆叠集成)。
诊断标准与关键数值
- 基于瘤内及瘤周2 mm区域的影像组学模型(VOI_Comb2)在内部验证集AUC=0.843,外部验证集AUC=0.803。
- 基于VOI_Comb2区域的3D深度学习模型在所有深度学习模型中AUC最高,内部验证集AUC=0.839,外部验证集AUC=0.814。
- soft voting融合策略在内部验证集AUC=0.925,外部验证集AUC=0.889。
- 外部验证集上,soft voting模型的AUC显著高于硬投票模型、早期融合模型或任何单模态模型。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: This study aims to analyze the intratumoral and peritumoral characteristics of lung adenocarcinoma patients on the basis of chest CT images via radiomic and deep learning methods and to develop and validate a multimodel fusion strategy for predicting epidermal growth factor receptor (EGFR) mutation statuses.
MATERIALS AND METHODS: Retrospective data from 826 lung adenocarcinoma patients across two hospitals were collected. Data from center1 were used for model training and internal validation, while data from center2 were reserved for external validation. Tumor segmentation was performed using the nnUNet network, and volumes of interest (VOIs) for the tumor and its peritumoral regions (2 mm, 4 mm, 6 mm, 8 mm, 10 mm) were subsequently derived.Radiomics features were extracted from various VOIs using PyRadiomics, and radiomics models were developed using Lasso and multiple machine learning algorithms.Using 2D, 2.5D, and 3D images derived from different VOIs as inputs, multiple deep learning models were trained and their performances compared.The radiomics and deep learning models demonstrating the best predictive performance were selected and integrated with clinical models for model fusion.Multi-model fusion of clinical, radiomics, and deep learning features was achieved using feature-level fusion and various decision-level fusion strategies, including hard voting, soft voting, and stacking ensemble.The predictive performances of various fusion models were evaluated and compared systematically.
RESULTS: Among the available radiomic models, the model based on intratumoral and peritumoral 2-mm regions (VOI_Comb2) achieved the best performance on the internal and external validation sets (AUC=0.843 and 0.803, respectively). Compared with 2D and 2.5D deep learning models, the 3D deep learning model demonstrated superior predictive performance. The 3D deep model based on the VOI_Comb2 region achieved the highest AUC among all the deep learning models on the internal and external validation sets (AUC=0.839 and 0.814, respectively). Among the fusion models, the soft voting strategy achieved the highest AUC on the internal and external validation sets, reaching 0.925 and 0.889, respectively. On the external validation set, the AUC of the soft voting model was significantly greater than that of the hard voting model, early fusion model, or any single modality model.
CONCLUSION: This study demonstrates that combining radiomic and deep learning models based on intratumoral and peritumoral regions is an effective method for capturing comprehensive imaging features in lung adenocarcinoma. The multimodal fusion approach using soft voting leverages the strengths of each modality and provides a robust framework for advanced image feature extraction to support personalized treatment.
引用
- Huang L, Xu L, Wang X, et al. Prediction of EGFR Mutations in Lung Adenocarcinoma via CT Images: A Comparative Study of Intratumoral and Peritumoral Radiomics, Deep Learning, and Fusion Models. Acad Radiol. 2025. PMID: 40328536. doi:10.1016/j.acra.2025.04.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。